Northeast Financial Group’s Eli Lilly LLY Stock Holding History

Northeast Financial Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$527K	Sell	573 -50	-8%	-$50.7K	0.13%	52
2025 Q4	$670K	Sell	623 -25	-4%	-$23.9K	0.15%	50
2025 Q3	$494K	Buy	648 +25	+4%	+$18.6K	0.12%	51
2025 Q2	$486K	Sell	623 -14	-2%	-$10.9K	0.14%	60
2025 Q1	$526K	Buy	637 +19	+3%	+$15.8K	0.18%	47
2024 Q4	$477K	Hold	618	–	–	0.18%	52
2024 Q3	$548K	Buy	618 +4	+0.7%	+$3.6K	0.2%	47
2024 Q2	$556K	Buy	614 +3	+0.5%	+$2.4K	0.24%	45
2024 Q1	$476K	Hold	611	–	–	0.21%	50
2023 Q4	$356K	Sell	611 -16	-3%	-$9.34K	0.17%	58
2023 Q3	$337K	Sell	627 -8	-1%	-$4.12K	0.21%	49
2023 Q2	$298K	Buy	635 +26	+4%	+$10.9K	0.19%	53
2023 Q1	$210K	Buy	609 +11	+2%	+$3.71K	0.15%	52
2022 Q4	$219K	Buy	+598	New	+$212K	0.17%	51

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northeast Financial Group's LLY Position: Q1 2026 in Review

Northeast Financial Group reduced its Eli Lilly (LLY) stake by 8% in Q1 2026, selling an estimated $50.7K and leaving 573 shares worth $527K. The position accounts for 0.13% of the portfolio, ranked #52.

Northeast Financial Group first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $670K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Northeast Financial Group held 573 shares of Eli Lilly worth $527K as of Q1 2026.
Northeast Financial Group sold 50 Eli Lilly shares in Q1 2026, an estimated $50.7K.
Eli Lilly made up 0.13% of Northeast Financial Group's portfolio in Q1 2026, its #52 holding.
Northeast Financial Group first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
Northeast Financial Group's Eli Lilly position peaked at $670K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Northeast Financial Group's 13F filing for Q1 2026, filed 15 May 2026.